Current Primary Outcome Measures •Numeric Rating Scale at 60 days and 90 days post procedure (lead removal) [ Time Frame: at 60 days (plus or minus 5 days) and 90 days (plus or minus 10 days) ] ...
CLEVELAND, Jan. 21, 2020 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, today announced publication of a prospective case series regarding its ...
Editor's note: This article has been updated to clarify FDA classification of the Sprint Peripheral Nerve Stinulation system. Cleveland, Ohio-based SPR Therapeutics announced today that it has ...
Philadelphia, PA, Oct. 30, 2017 (GLOBE NEWSWIRE) -- MossRehab, one of the country’s leading rehabilitation institutes in Elkins Park, Pa, (and part of Einstein Healthcare Network) is now offering the ...
As the clinical director of neuromodulation services at MossRehab, Michael Saulino is always looking for new ways to treat nerve pain in patients that don’t involve addictive opioids. “When it comes ...
Please provide your email address to receive an email when new articles are posted on . Published results showed percutaneous peripheral nerve stimulation may provide clinically meaningful and ...
SPR Therapeutics Inc., a Cleveland medical device company that's developed a neurostimulation platform for pain management, has announced the results of a study of its SPRINT Peripheral Nerve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback